[In vivo effect of streptonigrin on the ultrastructure of Yoshida ascites hepatoma].
D000818:Animals; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D003593:Cytoplasm / Q000187:drug effects; D008113:Liver Neoplasms; D008854:Microscopy, Electron; D008928:Mitochondria / Q000187:drug effects; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D010848:Picolinic Acids / Q000627:therapeutic use*; D011748:Pyrogallol / Q000627:therapeutic use*; D011804:Quinolines / Q000627:therapeutic use*; D051381:Rats; D013308:Streptonigrin / Q000494:pharmacology / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D010848:Picolinic Acids; D011804:Quinolines; D011748:Pyrogallol; D013308:Streptonigrin